⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors
Clinical trial NCT03802123 · COMPLETED
Trial details
- NCT number
- NCT03802123
- Sponsor
- ImaginAb, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2021-10-19
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.